Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (1)
  • (1)
  • (4)
  • (74)
  • (4)
Filter
11 - 20 of 109 results
  • High-THC Cannabis Smoke Impairs Incidental Memory Capacity in Spontaneous Tests of Novelty Preference for Objects and Odors in Male Rats | eNeuro
    Working memory is an executive function that orchestrates the use of limited amounts of information, referred to as working memory capacity, in cognitive functions. Cannabis exposure impairs working memory in humans; however, it is unclear whether Cannabis facilitates or impairs rodent working memory and working memory capacity. The conflicting literature in rodent models may be at least partly because of the use of drug exposure paradigms that do not closely mirror patterns of human Cannabis use. Here, we used an incidental memory capacity paradigm where a novelty preference is assessed after a short delay in spontaneous recognition-based tests. Either object or odor-based stimuli were used in test variations with sets of identical [identical stimuli test (IST)] and different [different stimuli test (DST)] stimuli (three or six) for low-memory and high-memory loads, respectively. Additionally, we developed a human-machine hybrid behavioral quantification approach which supplements stopwatch-based scoring ...
    Dec 1, 2023 Ilne L. Barnard
  • Repeated exposure to high-THC Cannabis smoke during gestation alters sex ratio, behavior, and amygdala gene expression of Sprague Dawley rat offspring | eNeuro
    Due to the legalization of Cannabis in many jurisdictions and trend of increasing THC content in Cannabis products, an urgent need exists to understand the impact of Cannabis use during pregnancy on fetal neurodevelopment and behavior. To this end, we exposed female Sprague-Dawley rats to Cannabis smoke daily from gestational days 6 to 20 or room-air. Maternal reproductive parameters, offspring behavior, and gene expression in the offspring amygdala were assessed. Body temperature was decreased in dams following smoke exposure and more fecal boli were observed in the chambers before and after smoke exposure in dams exposed to smoke. Maternal weight gain, food intake, gestational length, litter number, and litter weight were not altered by exposure to Cannabis smoke. A significant increase in the male-to-female ratio was noted in the Cannabis -exposed litters. In adulthood, male and female Cannabis smoke-exposed offspring explored the inner zone of an open field significantly less than control offspring. Ge...
    Nov 10, 2023 Thaisa M. Sandini
  • Repeated Exposure to High-THC Cannabis Smoke during Gestation Alters Sex Ratio, Behavior, and Amygdala Gene Expression of Sprague Dawley Rat Offspring | eNeuro
    Because of the legalization of Cannabis in many jurisdictions and the trend of increasing Δ9-tetrahydrocannabinol (THC) content in Cannabis products, an urgent need exists to understand the impact of Cannabis use during pregnancy on fetal neurodevelopment and behavior. To this end, we exposed female Sprague Dawley rats to Cannabis smoke daily from gestational day 6 to 20 or room air. Maternal reproductive parameters, offspring behavior, and gene expression in the offspring amygdala were assessed. Body temperature was decreased in dams following smoke exposure and more fecal boli were observed in the chambers before and after smoke exposure in dams exposed to smoke. Maternal weight gain, food intake, gestational length, litter number, and litter weight were not altered by exposure to Cannabis smoke. A significant increase in the male-to-female ratio was noted in the Cannabis -exposed litters. In adulthood, male and female Cannabis smoke-exposed offspring explored the inner zone of an open field significantl...
    Nov 1, 2023 Thaisa M. Sandini
  • Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation | Journal of Neuroscience
    Evidence suggests that the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) differentially regulate salience attribution and psychiatric risk. The ventral hippocampus (vHipp) relays emotional salience via control of dopamine (DA) neuronal activity states, which are dysregulated in psychosis and schizophrenia. Using in vivo electrophysiology in male Sprague Dawley rats, we demonstrate that intra-vHipp THC strongly increases ventral tegmental area (VTA) DA neuronal frequency and bursting rates, decreases GABA frequency, and amplifies VTA beta, gamma and ε oscillatory magnitudes via modulation of local extracellular signal-regulated kinase phosphorylation (pERK1–2). Remarkably, whereas intra-vHipp THC also potentiates salience attribution in morphine place-preference and fear conditioning assays, CBD coadministration reverses these changes by downregulating pERK1–2 signaling, as pharmacological reactivation of pERK1–2 blocked the inhibitory properties of CBD. These results identify vHipp...
    Oct 30, 2019 Roger Hudson
  • Differential Effects of Presynaptic versus Postsynaptic Adenosine A2A Receptor Blockade on Δ9-Tetrahydrocannabinol (THC) Self-Administration in Squirrel Monkeys | Journal of Neuroscience
    Different doses of an adenosine A2A receptor antagonist MSX-3 [3,7-dihydro-8-[(1E)-2-(3-ethoxyphenyl)ethenyl]-7 methyl-3-[3-(phosphooxy)propyl-1-(2 propynil)-1H-purine-2,6-dione] were found previously to either decrease or increase self-administration of cannabinoids delta-9-tetrahydrocannabinol (THC) or anandamide in squirrel monkeys. It was hypothesized that the decrease observed with a relatively low dose of MSX-3 was related to blockade of striatal presynaptic A2A receptors that modulate glutamatergic neurotransmission, whereas the increase observed with a higher dose was related to blockade of postsynaptic A2A receptors localized in striatopallidal neurons. This hypothesis was confirmed in the present study by testing the effects of the preferential presynaptic and postsynaptic A2A receptor antagonists SCH-442416 \[2-(2-furanyl)-7-[3-(4-methoxyphenyl)propyl]-7H-pyrazolo[4,3-e\]\[1,2,4\]triazolo[1,5-c]pyrimidin-5-amine] and KW-6002 [(E)-1, 3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purin...
    May 7, 2014 Zuzana Justinová
  • Abstract
    Effects of tetrahydrocannabinol (THC) on Cerebral Blood Flow in Humans Measured using Arterial Spin Labeling (ASL).
    Marijuana and its principal psychoactive component, THC, produce characteristic behavioral and physiological effects in humans. However, THC's sites of action in the human brain and their relationships to the drug's actions are not yet well understood. We have previously demonstrated using BOLD fMRI imaging that THC produced dose-related alterations in brain function in several brain regions including nucleus accumbens, amygdala, anterior cingulate, and cerebellum. The purpose of the this study was to determine the relative contributions of neuronal and non-neuronal factors to the observed BOLD signal changes. With that in mind, we examined the effects of THC on cerebral blood flow using arterial spin labeling. Chronic marijuana users were injected iv with THC (0, 0.5, 1, and 3 mg over one-minute in an ethanol vehicle) while undergoing fMRI scanning. A single 8 mm slice containing motor cortex was imaged during rest and motor cortex activation (finger tapping). We found the average flow in the slice at res...
    Nov 7, 2002
  • Abstract
    Self-administration behavior maintained by delta-9-tetrahydrocannabinol the psychoactive ingredient of marijuana in squirrel monkeys.
    The abuse potential of marijuana in humans is well established but scientific evidence for reinforcing properties of its psychoactive constituent delta-9-tetrahydrocannabinol (THC) in animals is lacking. In the present experiments, high rates of self-administration behavior were consistently maintained in squirrel monkeys by intravenous injections of THC. Mean rates of responding ranged from 0.1 to 0.4 response/sec during daily 1-hr sessions, using a fixed-ratio 10, time-out 60 sec, schedule of i.v. THC injection with doses of 2 to 4 mcg/kg/injection. A second-order, fixed-interval schedule with fixed-ratio components was also studied, in which THC was repeatedly injected only at the end of each daily session in association with a brief visual stimulus (each completion of a fixed-ratio unit during a 30-min fixed interval produced only the brief visual stimulus). Mean rates of responding ranged from 0.06 to 0.2 responses/sec when 10 consecutive injections of 2 to 4 mcg/kg/injection THC spaced 2-sec apart en...
    Nov 5, 2000
  • Abstract
    Acute marijuana effects on rCBF and cognition.
    We have previously reported PET rCBF data from 5 volunteers following smoking of a marijuana cigarette (SNS 1998). The present study measured rCBF with PET using [O-15]water in 12 new volunteers (6M, 6F) who were occasional recreational users of marijuana. Subjects were imaged prior to and following smoking of a marijuana (20 mg THC) and placebo (marijuana with THC removed) cigarette as they repeatedly performed an auditory attention task. A double-blind design was used with order of THC and placebo counterbalnced across subjects. Subtraction of the post-placebo from the post-THC condition revealed dramatic rCBF increases in orbital frontal cortex, anterior cingulate, temporal pole, insula, and lateral cerebellum. Smoking marijuana decreased rCBF in L heschl’s gyrus, primary visual cortex, and a number of frontal regions (BA4, 6, 8, 10). Ventral brain regions showing increased rCBF may mediate the intoxicating and mood-related effects of smoking marijuana. The rCBF decreases in primary sensory cortices and...
    Nov 5, 2000
  • Abstract
    Potentialisation of Δ9-tetrahydrocannabinol effects by nicotine.
    Recent findings have provided the existence of a functional interaction between opioid, dopaminergic and cannabinoid systems on addictive related behaviours. We have analysed the consequences of nicotine administration on the behavioural responses induced by Δ9-tetrahydrocannabinol (THC). For this purpose, we have administrated THC (5 or 10 mg/kg) and nicotine (0.5 mg/kg) and evaluated acute responses, the development of tolerance and the somatic expression of THC withdrawal. Nicotine strongly potentiates hypothermia, antinociceptive responses and the decrease of locomotor activity induced by an acute injection of THC. The development of tolerance to THC responses was also modified by nicotine. Indeed, animals treated with THC alone developed a rapid tolerance to all the acute pharmacological responses. In contrast, the co-administration of nicotine decreased the degree of THC tolerance. Acute injection of the CB1 receptor antagonist SR 141716A (10 mg/kg) in THC-dependent mice precipitated somatic signs of...
    Nov 5, 2000
  • Abstract
    TETRAHYDROCANNABINOL INDUCES APOPTOSIS IN CORTICAL NEURONES.
    E. Downer and V. Campbell. * Dept. of Physiology, Trinity College Dublin, Ireland. Δ9-Tetrahydrocannabinol (THC), the principle psychoactive component of marijuana, elicits diverse psychological effects in humans. At a cellular level THC has been shown to have both neurotoxic1 and neuroprotective effects2. The aim of this study was to examine the role of the stress activated protein kinase (SAPK) c-jun N-terminal kinase (JNK) in THC-induced neurotoxicity in cortical neurones. Treatment of cultured cortical neurones with THC (5µM) for 2h resulted in a 49% increase in genomic DNA strand breaks as assessed by TUNEL staining (p<0.01, paired t-test, n=10). Use of a fluorogenic assay has revealed that caspase-3 activity is increased from 13±6 pmol AFC produced/mg/min (mean±SEM) to 24±8 pmol AFC produced/mg/min following treatment of neurones with THC for 2h. Western Blot analysis showed that cell death was preceded by JNK activation (p<0.05, ANOVA, n=6). The specific role of JNK in this system was assessed by do...
    Nov 7, 2002
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Featured

  • Explore the benefits of an SfN membership
  • Upcoming Webinar: Behavioral and Evolutionary Adaptations to Changing Environments
  • Seeburg Prize nominations have been extended to February 19
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience